Editor's Picks

Shares of Pfizer are down over 12.5% since the start of 2022. Plan to spend cash generated from COVID-19 vaccine on M&As and share buybacks. Long-term investors may consider buying PFE stock at...

The dollar extended a decline from a 20-year high, on lower than anticipated US economic data releases. The greenback slid on Friday after US consumer morale hit an all-time low, as measured by the...

Reports fiscal Q4 2022 results on Monday, June 27, after the close Revenue expectation: $12.09 billion EPS expectation: $1.07 The current economic environment doesn't seem conducive for sportswear...

Russia defaults China eases COVID restrictions Rally in Bitcoin continues Key EventsOn Monday US futures on the Dow Jones, S&P 500, NASDAQ 100, and Russell 2000 as well as global markets...

This article was written exclusively for Investing.comAs theater goes, the semiannual Monetary Policy Report to Congress (MPC) testimony is pretty thin gruel. But beggars can’t be choosers and,...

This article was written exclusively for Investing.comIt's exceptionally easy to make the bear case for Spotify (NYSE:SPOT) stock. Even with the shares off 54% year-to-date and 65% from their 2021...

Around the Father’s Day and Juneteenth holidays in the US this month, thousands of flights were canceled creating what some dubbed a ‘travel Armageddon,’ impacting millions of...

This week’s anticipated rebound in crude oil could be stalled by G7 plans to revive the Iran nuclear deal for a workaround to the Russian oil squeeze, a proposition that comes amid lingering...